Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process

by Bahez Gareb, Silke Posthumus, Max Beugeling, Pauline Koopmans, Daan J. Touw, Gerard Dijkstra, Jos G.W. Kosterink, Henderik W. Frijlink
Published 2019-08-01

Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study

by Max Beugeling, Katie Amssoms, Freek Cox, Ben De Clerck, Ellen Van Gulck, Jeroen A. Verwoerd, Guenter Kraus, Dirk Roymans, Lieven Baert, Henderik W. Frijlink, Wouter L. J. Hinrichs
Published 2019-10-01

Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice.

by Katie Amssoms, Philip A Born, Max Beugeling, Ben De Clerck, Ellen Van Gulck, Wouter L J Hinrichs, Henderik W Frijlink, Niels Grasmeijer, Guenter Kraus, Roger Sutmuller, Kenny Simmen, Lieven Baert
Published 2018-01-01